Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-1944 in Healthy Adults

Clinical trial NCT03829384 · COMPLETED

Trial details

NCT number: NCT03829384
Sponsor: ModernaTX, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prevention of Chikungunya Virus Infection

Start date: 2019-01-22
Primary completion: 2021-06-07
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.